<DOC>
	<DOC>NCT00566774</DOC>
	<brief_summary>The objective of this randomized trial is to evaluate the effect of providing full prescription drug coverage (i.e. no co-pays, co-insurance or deductibles) for statins, beta-blockers, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers to patients recently discharged from hospital after acute myocardial infarction.</brief_summary>
	<brief_title>A Randomized Evaluation of First-dollar Coverage for Post-MI Secondary Preventive Therapies</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>discharged alive from hospital after acute MI receive health services and prescription drug benefits through Aetna, Inc. enrollment in a Health Savings Account (HSA) plan age â‰¥ 65 years of age at the time of hospital discharge plan sponsor has opted out of participating in the study receive only medical services or pharmacy coverage but not both through Aetna</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>myocardial infarction</keyword>
	<keyword>secondary prevention</keyword>
	<keyword>health insurance</keyword>
	<keyword>cost-sharing</keyword>
</DOC>